Edesa Biotech Inc (NASDAQ:EDSA) currently has a daily average trading volume of 26.76K but it saw 114769805 shares traded in last market. With a market cap of 11.27M USD, the company’s current market price of $3.25 came rising about 74.73 while comparing to the previous closing price of $1.86. In past 52 weeks, the stock remained buoying in the range of price level as high as $5.99 and as low as $1.55. In the recent trading on the day, stock has struck highest price mark of $2.83 while lowest mark touched by it was $4.4899.
Taking a look at 20-day trading activity of Edesa Biotech Inc (EDSA) gives us an average price of $1.9600, while its current price level is -45.74% below from 52-week high level whereas it is 109.68% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.9100 while that of 200 days or SMA-200 reads an average of $3.5800. A closer look into the stock’s movement over the week reveals that its volatility is standing at 17.81% during that period while stretching the period over a month that decreases to 12.61%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 80.92 which implies that the stock is in overbought territory.
Over the week, EDSA’s stock price is moving 66.36% up while it is 104.42% when we observe its performance for the past one month. Year-to-date it is 93.45% up and over the past year, the stock is showing a downside performance of -37.62%.
The company is expected to be releasing its next quarterly report in March, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Edesa Biotech Inc’s total number of outstanding shares is 3.25M with 33.22% of that held by the insiders while 12.20% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -311.44% and return on equity (ROE) at -136.66%. Stock’s beta reads 0.80. Stock has a price to book (P/B) ratio of 5.33. Its return on asset (ROA) is -94.46% on average.
